How Auditors Are Tackling AI in Life Sciences: From Warning Letters to Assurance Architecture
FDA issued its first AI-focused cGMP warning letter. MHRA caught AI-generated inspection responses citing nonexistent regulations. EMA is writing Annex 22 specifically for AI in GMP. The audit profession is fundamentally rewiring how it evaluates AI — and most biopharma companies aren't ready.
Read Article →
Saram Consulting